The Unnatural Origins of the Wuhan Pandemic Part 5: Misdirection and Cover Up in The West

The Unnatural Origins of the Wuhan Pandemic
Since we started this series of articles, the possibility of SARS-CoV-2 having originated from a laboratory in Wuhan has recently started to be debated in the Western media, particularly in USA. This change can be put down to two recent revelations: that the US State Department has evidence of three laboratory workers in the Wuhan Institute of Virology becoming infected with a respiratory disease in early November which necessitated their hospitalisation, and the discovery on 12th May of a number of Chinese academic theses detailing gain of function research on previously unpublis...

To continue reading this post...

Subscribe To Gain David's Insights

Read David's Murrinations in full on the website, predictions, strategy and analysis, covering the latest significant financial, geopolitical and environmental developments around the world.

Read the newspapers for yesterday's news or read David's Murrinations for future trends and strategies.

A subscription will give you instant online access, as opposed to a 6 week delay for non-subscribers.

Choose Your Subscription

Free Trial
Start a 14 day free trial now


Start Free Trial

3 Month Subscription
£50 per month


Buy Subscription

Annual Subscription
£40 per month


Buy Subscription

Prices excluding VAT (UK only).

If you are already a subscriber login here

Free Arkite Membership

You will receive Arkite Alerts with invites to webinars, information relating to the site development and urgent heads up on very significant events. You will also receive Murrination email alerts but will not be able to click through and read them in full for 6 weeks.

Strategic Market Perspectives and Financial Market Analysis & Forecasts

David also offers Arkent Scenario Updates - unified strategic market perspectives and Financial Market Analysis & Forecasts - real time trade recommendations across Equity Indices, FX, Bonds, Emerging Markets and Commodities.